Leukemia M2 is usually recommended to be treated conservatively when it is not suitable for bone marrow transplantation.
If leukemia M2 can meet the conditions for bone marrow transplantation, bone marrow transplantation is generally recommended as soon as possible to prolong the patient’s survival time and improve the patient’s quality of life; some patients do not meet the conditions for bone marrow transplantation, conservative treatment is generally recommended.
Conservative treatment for leukemia M2 is mainly based on chemotherapy, and chemotherapy drugs can be chosen from cytarabine, Zoerythromycin, etc. The selection should be based on the degree of sensitivity to the drugs and a set of optimal treatment plan should be formulated under the guidance of the doctor.
After the detection of leukemia M2, treatment should be carried out in a timely manner, so as not to delay the condition and lead to a shortened survival rate. The specific treatment plan should be carried out in accordance with the doctor’s instructions, to avoid unauthorized use of drugs.